The rapid mass testing strategy costing just £1 a day per child can get children back to school and economies up and running, according to experts.
That is the small price of the rapid mass testing across schools in the UK, which is also hard on the heels of one of the world’s swiftest and most successful vaccination programmes.
A double whammy of rapid testing and vaccine deployment applied internationally could lead to a reduction of the human and economic hardship caused by much-criticised lockdown strategies, as well as the continued failure of ‘Track and Trace,’ which has swallowed up £32 billion in the UK.
The UK Government’s investment in vaccines started early, but its equally far-sighted adoption of inexpensive lateral flow test (LFT) kits is less well known.
The economical LFT utilizes nanoparticles to detect virus fragments in a test sample, identifying whether a subject is SARS-CoV-2 asymptomatic within 30 minutes. An individual can immediately isolate after a positive test, preventing transmission of COVID-19 at a rapid pace.
Some early scepticism about the devices has since been overwhelmed by new data and a robust rebuttal from Dr Susan Hopkins, COVID-19 Strategic Response Director to Public Health England, who said:
“Up to one in three people who have coronavirus never show any symptoms (asymptomatic) but that does not mean they are not infectious. Using LFTs enables us to rapidly identify people in the population who are asymptomatic, with results produced in 30 minutes.
“Lateral flow devices are effective at finding people with high viral loads who are most infectious and most likely to transmit the virus to others.”
And she added that the latest data suggested LFTs “are at least 99.9% specific which means that the risk of false positives is extremely low – less than one in a thousand.”
UK Government-sponsored LFT use in workplaces is already widespread, with nearly 50,000 UK businesses already registered for free kits, so that employees can be tested at least twice a week with fast results, enabling them to return to work and their children to get back into the classroom.
Each pupil must take two tests (£3.50 each) a week to show whether they need to be taken out of class to avoid infecting others and the same approach will be used for parents in the workplace.
“That’s remarkable value-for-money. £1 a day for an ‘insurance policy’ to enable schools to open, mums and dads to properly return to work, and the country to accelerate out of lockdown with the re-opening of hospitality and major venues no longer a distant prospect,” said Paul Sheedy, Co-founder of the not-for-profit World Nano Foundation (WNF) that promotes healthcare innovation and believes mass testing kits using nanotechnology are central to future pandemic protection.
Image Credit: Nano
Post by Amanda Scott, NA CEO. Follow her on twitter @tantriclens
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News
Hundreds of AI tools have been built to catch covid – None of them helped
When covid-19 struck Europe in March 2020, hospitals were plunged into a health crisis that was still badly understood. “Doctors really didn’t have a clue how to manage these patients,” says Laure Wynants, an [...]
Two doses of Pfizer, AstraZeneca COVID-19 shots effective against delta variant, study finds
Pfizer found to be 88 per cent effective at preventing symptomatic disease from delta variant. Two doses of Pfizer-BioNTech or AstraZeneca-Oxford's COVID-19 vaccines are nearly as effective against the highly transmissible delta coronavirus variant [...]
S.Africa’s Aspen releases first batch of Johnson vaccine
South African pharmaceutical company Aspen said Monday it was releasing its first batch of African-produced COVID-19 vaccines under a licensing deal with the US giant Johnson & Johnson. The Durban-based company said the first [...]
COVID-19 Variants: What the Future Could Look Like After the Pandemic
Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and [...]
Delta variant of SARS-CoV-2 will likely be dominant strain globally within months
The highly transmissible delta variant of SARS-CoV-2, the coronavirus causing the disease COVID-19, is now present in 124 countries and will become the dominant strain globally in the coming months as it is outcompeting [...]
UK scientists back Covid boosters as study finds post-jab falls in antibodies
Scientists have backed proposals for Covid boosters in the autumn after blood tests on hundreds of people revealed that protective antibodies can wane substantially within weeks of second vaccine shots being given. Falls in [...]
Pfizer-BioNTech and Moderna COVID-19 vaccines establish recall responses to reinfection
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall [...]
Study shows new ‘warm vaccine’ effective against all key virus variants
CSIRO, Australia's national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax—against all current SARS-CoV-2 variants of concern. Published [...]
Podcast – Nanovisaging 2040 How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit Humanity
Frank Boehm (NanoApps Medical Inc. Founder) in discussion with Nana Kay in a Wealth Secrets podcast. EP 19. Nanovisaging 2040. From Nana Kay: Nanovisaging 2040: How Synergies between Nanotechnology, Nanomedicine, and AI might Benefit [...]
Data in favour of mixing COVID-19 vaccines, but long-term effects unknown
Canada, like several other countries, has been mixing and matching COVID-19 vaccines for weeks amid safety concerns over the AstraZeneca shot. On Monday, the chief scientist at the World Health Organization (WHO) cautioned against that approach, calling [...]
CRISPR stops coronavirus replication in human cells
Scientists have harnessed CRISPR gene-editing technology to block the replication of the novel coronavirus in human cells — an approach that could one day serve as a new treatment for COVID-19. However, the study was performed [...]
Controlling the Size of Nanoparticles
Depositing nanoparticles using the NL50 is now simpler than ever with the pre-loaded optimized recipes for a variety of frequently used materials, including Au, Ag, Pt and Cu. These optimized recipes generate high-quality nano-coatings [...]
Shape of Nanoparticles in Body Fluids – a Biomarker for Identifying Cancer Types?
A recent study by scientists from Japanese universities has shown that the shape of cell-derived nanoparticles, known as "extracellular vesicles" (EVs), in body fluids could be a biomarker for identifying types of cancer. In [...]
Study reveals how our immune system reacts to COVID-19 variants
An important lesson for vaccine design Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not [...]
COVID-19: What you need to know about the coronavirus pandemic on 8 July
1. How COVID-19 is affecting the globe Confirmed cases of COVID-19 have passed 185 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4 million. More than 3.29 [...]
Here’s what you should know about the Lambda variant
The World Health Organization (WHO) has added another COVID strain to its list of coronavirus variants to keep an eye on: the COVID-19 Lambda variant. This particular variant has now spread to more than two dozen [...]
